NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against MoonLake Immunotherapeutics ("MoonLake" or "the Company") (NASDAQ:MLTX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants […]

Custom Embroidered Beanies Starting at $9.95 and Hats at $10.95 – Wholesale Pricing for Businesses and Brands Star Hats & Embroidery has introduced its Season Deals – Embroidered Hats and Beanies collection, offering businesses affordable, premium-quality custom embroidered headwear ahead of the holiday season. Custom embroidered beanies starting at $9.95 and custom embroidered hats starting

RADCOM Ltd. (NASDAQ: RDCM)announced today that it will release its financial results for the third quarter, ended September 30, 2025, on Wednesday, 12, November, 2025 before the opening of trade on the Nasdaq Stock Market. RADCOM CEO Benny Eppstein and CFO Hadar Rahav will host a conference call and live webinar on the same day

Flare Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate FX-909 in Combination with KEYTRUDA(R) (pembrolizumab) in New Cohort of Ongoing Phase 1 Trial in Metastatic Urothelial Cancer GlobeNewswire October 21, 2025 CAMBRIDGE, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) — Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to

HanchorBio today announced that its proprietary HCB101, a SIRPa/CD47 fusion protein candidate, has been officially granted a US patent (Patent No. 12,447,195) by the United States Patent and Trademark Office (USPTO). Titled “ENGINEERED SIRPa VARIANTS AND METHODS OF USE THEREOF”, the patent represents major international recognition for the company's innovative technology for immuno-oncology. Mechanism of

Enhancements to the industry-leading high-performance computing and cloud platform elevate next-generation computing Altair, a global leader in computational intelligence, today announced significant upgrades to theAltair® HPCWorks® high-performance computing (HPC) and cloud platform. The release of Altair HPCWorks 2026 enables faster discovery with new features and improvements including enhanced GPU integration and utilization, expanded AI and

The collaboration provides field technicians with immediate access to model-specific information, embedded within the software they already know and trust Housecall Pro®, a top software platform built to empower home service contractors, announces a strategic partnership and integration withBluon, Inc., the HVAC industry's leading provider of technical data and AI-powered support tools. This in-app integration

The collaboration equips Housecall Pro users with HVAC's most powerful support toolkit to augment their technicians and combat the skilled labor shortage Bluon, Inc., an innovative software company that provides indispensable technical data and support via its proprietary database and AI platform to boost productivity for HVAC contractors and their service technicians, today announced a

Joint contribution highlights the insurance industry's role in investing in the long-term well-being of Canadians The Western Communities Foundation, the charitable arm of Western Financial Group, in partnership with Wawanesa Insurance are proud to make a joint $100,000 donation to the Health Sciences Centre (HSC) Foundation's Operation Excellence Campaign. This impactful contribution supports surgical innovation

Hengrui Pharma and Kailera Therapeutics Announce Phase 3 HRS9531 Obesity Data Presentation at ObesityWeek(R) 2025 Results from Hengrui's completed Phase 3 clinical trial of HRS9531, a novel dual GLP-1/GIP receptor agonist with potentially best-in-category weight loss, to be presented in an oral session GlobeNewswire October 21, 2025 SHANGHAI and WALTHAM, Mass., Oct. 21, 2025 (GLOBE